Fate Pharma (FATE) - Yalpi foyda normasi

Fate Therapeutics Corp (FATE) kompaniyasining rasmiy ramzlari

Fate Therapeutics, Inc. (FATE) saratonning ilg'or immunoterapiyasini ishlab chiqmoqda, uning rivojlanishi iqtisodiy sikllardan mustaqil, ammo ventura kapitaliga tayanadi. GURU.Markets servisida yalpi foyda tebranishlari xarajatlar samaradorligini ko'rsatuvchi chiziqli grafik mavjud bo'lib, -140.80 ko'rsatkichi joriy darajani tasdiqlaydi. Daromadlar og'ir o'smalarni davolash uchun sug'urta kompaniyalari tomonidan amalga oshirilgan to'lovlarga asoslangan, robototizatsiyalashgan tizimlar esa tanaffussiz ishlaydi.

fatetherapeutics.com (FATE) - Yalpi marja 04.07.2022dan 20.11.2026gacha

Fate Therapeutics, Inc. (FATE) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
Fundamental baholash:Fate Therapeutics, Inc.
Fate Pharma brend mahsuloti

Investorlar operatsion samaradorlik tendentsiyalari orqali kapitalga yo'naltirilgan fundamental tahdidlarni baholamoqda va hisobotlar e'lon qilinishidan oldin yashirin xarajatlar o'sishini aniqlamoqda. Fate Therapeutics, Inc. (FATE) kompaniyasining diversifikatsiyalashgan hujayralar terapiyasi loyihalari ulkan xarajatlarni talab qiladi; shuning uchun GURU.Markets platformasidagi yalpi foyda foizi sotilgan tovarlar tannarxini chegirib tashlagandan keyin kompaniyaning daromadni saqlab qolish qobiliyatini aks ettiradi, bunda grafikdagi har qanday keskin pasayish ishlanmalarning daromadliligining kritik darajada kamayganidan dalolat beradi.

Asosiy raqobatchilar

Yalpi foyda marjasi BeiGene Ltd. (ONC)|Yalpi foyda bo'yicha rentabellik HALO|Yalpi rentabellik RVMD|Yalpi foyda bo'yicha rentabellik AAPG (Ascentage)|Yalpi foyda bo'yicha rentabellik cgoncology.com CGON|UroGen Pharma - Yalpi foyda bo'yicha rentabellik|Yalpi foyda normasi BCAX|PSNL - Yalpi rentabellik|Yalpi foyda bo'yicha sotuv rentabelligi Erasca Oncology ERAS|delcath.com (DCTH) - Yalpi rentabellik|Y-mAbs Therapeutics - Yalpi foyda normasi|AURA (Aura Biosciences Inc) - Yalpi marja|Yalpi foyda marjasi candeltx.com CADL|Yalpi marja ARAY|SLS (SELLAS Life Sciences Group, Inc.) - Yalpi foyda normasi|Yalpi rentabellik Actuate Therapeutics, Inc. ACTU|citiusonc.com - Yalpi rentabellik|TuHURA Biosciences Inc. - Yalpi marja|TARA - Yalpi marja|WHWK: Yalpi marja|TScan Therapeutics (TCRX) - Yalpi marja|Yalpi rentabellik Champions Oncology|Yalpi rentabellik XBIT|Yalpi marja CVM|Yalpi foyda bo'yicha rentabellik OS Therapies Inc. OSTX|Yalpi rentabellik Radiopharm Theranostics Limited RADX|artivabio.com (ARTV) - Yalpi foyda marjasi|ANL - Yalpi rentabellik|Yalpi foyda marjasi verupharma.com|TPST: Yalpi marja|XLO - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi rentabellik Renovaro|Yalpi marja muraloncology.com|Yalpi marja KAPA|Yalpi foyda bo'yicha sotuv rentabelligi OnKure Therapeutics, Inc.|Yalpi marja GDTC (w2.cytomed.sg)|CRIS - Yalpi foyda bo'yicha rentabellik|Apollomics - Yalpi marja|Tharimmune Corp (THAR) - Yalpi foyda bo'yicha rentabellik|ADVB: Yalpi marja|Yalpi foyda bo'yicha rentabellik Genprex|CLDI (Calidi Biotherapeutics, Inc.) - Yalpi marja|Sotuvning yalpi rentabelligi SBFM (Sunshine Biopharma)|Yalpi rentabellik Xenetic Bio (XBIO)|Yalpi rentabellik SLRX (Salarius Pharma)|Kitov Pharma - Yalpi foyda bo'yicha rentabellik|American Oncology Network (AONC) - Yalpi foyda marjasi|BeiGene - Yalpi marja|Checkpoint Therapeutics, Inc. (CKPT) - Yalpi foyda bo'yicha rentabellik|ELEV (Elevation Oncology, Inc.) - Yalpi foyda bo'yicha rentabellik|iCAD Inc. - Yalpi foyda normasi|Yalpi foyda bo'yicha rentabellik IKNA|Yalpi marja notablelabs.com|Yalpi foyda bo'yicha rentabellik VIRX (Viracta Therapeutics Inc.)|MOR - Yalpi foyda marjasi|Yalpi rentabellik NAYA Biosciences NAYA|AAPGV - Yalpi foyda bo'yicha rentabellik